Synaptic loss in behavioural variant frontotemporal dementia revealed by UCB-J PET

Synaptic loss is an early feature of neurodegenerative disease models, and is often severe in post mortem clinical studies, including frontotemporal dementia. Positron emission tomography (PET) imaging with radiotracers that bind to synaptic vesicle glycoprotein 2A enables quantification of synapses in vivo. This study used [11C]UCB-J PET in people with behavioural variant frontotemporal dementia (bvFTD), testing the hypothesis that synaptic loss is severe and related to clinical severity. We performed a cross-sectional observational study of bvFTD, versus healthy controls, in which participants underwent neurological examination, neuropsychological assessment, magnetic resonance imaging (MRI) and [11C]UCB-J PET. Patients were recruited from the Cambridge Centre for Frontotemporal Dementia at the University of Cambridge, and healthy volunteers from the UK National Institute for Health Research Join Dementia Research register. Eleven people with a clinical diagnosis of probable bvFTD and 25 age- and sex-matched healthy controls were included. All participants underwent dynamic [11C]UCB-J PET imaging, structural MRI and a neuropsychological battery, including the Addenbrooke's cognitive examination (ACE-R), and INECO frontal screening (IFS). General linear models were used to compare [11C]UCB-J binding potential maps between groups, and correlate synaptic density with cognitive performance and clinical features in patients. Group-comparison and correlation analyses were also performed using partial-volume corrected [11C]UCB-J binding potential from regions of interest (ROIs). Patients with bvFTD showed severe synaptic loss compared to controls. In particular, [11C]UCB-J binding was significantly reduced bilaterally in medial and dorsolateral frontal regions, inferior frontal gyri, anterior and posterior cingulate gyrus, insular cortex and medial temporal lobe. Synaptic loss in the left frontal and cingulate regions correlated significantly with cognitive impairments as assessed with ACE-R and IFS. Results from ROI-based analyses mirrored the voxel-wise results. In keeping with preclinical models, and human post mortem data, there is widespread frontotemporal loss of synapses in symptomatic bvFTD, in proportion to disease severity. [11C]UCB-J PET could support translational studies and experimental medicines strategies for new disease-modifying treatments for neurodegeneration.

Foundation Trust and the University of Cambridge. Twenty-five healthy volunteers were recruited from the UK National Institute for Health Research Join Dementia Research (JDR) register.
Participants were screened for exclusion criteria: current or recent history (within the last 5 years) of cancer, current use of the anti-convulsant medication levetiracetam (that binds to SV2A, the target of [ 11 C]UCB-J), history or MRI evidence of ischaemic or haemorrhagic stroke, any severe physical illness or co-morbidity that would limit the ability to fully and safely participate in the study, and any contraindications to MRI. Eligible volunteers underwent a clinical and

Imaging acquisition and processing
Full details of the protocol for [ 11 C]UCB-J synthesis, data acquisition, image reconstruction and kinetic analysis have been published elsewhere (Holland et al., 2020;Milicevic Sephton et al., 2020;Malpetti et al., 2021). In brief, dynamic PET data acquisition was performed on a GE SIGNA PET/MR (GE Healthcare, Waukesha, USA) for 90 minutes following [ 11 C]UCB-J injection, with attenuation correction including the use of a multi-subject atlas method (Burgos et al., 2014) and improvements to the brain MRI coil component (Manavaki et al., 2019). Each emission image series was aligned and rigidly registered to T1-weighted MRI acquired in the same session (TR=3.6 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
For each subject a [ 11 C]UCB-J BP ND map was determined from dynamic images corrected for partial volume effects at the voxel level using the iterative Yang method (Erlandsson et al., 2012). BP ND was calculated using a basis function implementation of the simplified reference tissue model, with centrum semiovale as the reference tissue (Rossano et al., 2019). Each BP ND map was warped to the ICBM 152 2009a asymmetric MR template using parameters from the spatial normalisation of the co-registered T1 MR image with Advanced Normalization Tools (ANTs; http://www.picsl.upenn.edu/ANTS/). For voxel-wise analyses, the spatially normalised [ 11 C]UCB-J BP ND maps were spatially smoothed with a 10 mm full width at half maximum (FWHM) gaussian kernel prior to statistical analysis.
For regional analysis, we used the n30r83 Hammers atlas (http://brain-development.org) modified to include segmentation of brainstem and cerebellum, and non-rigidly registered to the T1-weighted MRI of each participant. Regions were multiplied by a binary grey matter mask constructed in Statistical Parametric Mapping (SPM12 v7771, Institute of Neurology, London, UK) based on a >50% probability map smoothed to PET spatial resolution, and geometric transfer matrix partial volume correction was applied to each image of the dynamic series (Rousset et al., 1998). Regional BP ND was determined with the same kinetic modeling approach and reference tissue as for the BP ND maps. separate models (for IFS, the analyses used 10 patients due to missing data). Similar models were applied to test for associations between [ 11 C]UCB-J BP ND , age and symptom duration. All results were tested at an uncorrected voxel height threshold of p < 0.001 combined with a familywise error (FWE) corrected cluster threshold of p < 0.05; peak voxels in clusters that reached the conservative voxel-level familywise error threshold (FWE p <0.05) are also indicated.
We performed complementary analyses on regions of interest, using R version 4.0.0 (R Core team 2020, https://www.r-project.org/) and JASP (JASP team: https://jasp-stats.org/). [ 11 C]UCB-J BP ND values from regions of interest were aggregated into left and right frontal lobe, temporal lobe, parietal lobe, occipital lobe, cingulate cortex, and included in the analyses alongside insula cortex, hippocampus, amygdala, and thalamus. First, two-sample t-tests were performed in each region to compare the bvFTD group to controls. Across all brain regions, p-values from t-tests were corrected with false-discovery rate (FDR) correction, and Cohen's d effect sizes were calculated. As explorative analyses, we also performed two-sample t-tests on [ 11 C]UCB-J BP ND values of bvFTD group vs controls considering smaller regions, obtained from the Hammers atlas with and without partial-volume correction. Second, Spearman's correlation analyses were performed to test the association between cognitive performance and [ 11 C]UCB-J BP ND in cortical regions. In addition to the above frequentist statistics, we also present Bayesian analogous tests for regional effects (https://osf.io/gny35/), furnishing the strength of the evidence for the null vs alternate hypotheses.

Data Availability Statement
Anonymized data may be shared upon request to the corresponding or senior author from a qualified investigator for non-commercial use, subject to restrictions according to participant consent and data protection legislation.

Results
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Descriptive statistics
Demographic and clinical features for the two groups are given in Table 1. The groups were similar in age and sex, with cognitive deficits among patients typical for bvFTD.

Voxel-wise group comparisons and correlations with cognitive scores
Single-subject [ 11 C]UCB-J BP ND maps for individual patients and the average BP ND map across all controls are reported in Figure 1. People with bvFTD showed mild (patient 1) to severe (patient 11) regional synaptic loss compared to controls.
At the FWE-corrected voxel-level threshold (p<0.05), the two-sample t-test on [ 11 C]UCB-J BP ND maps revealed synaptic loss in the bvFTD group compared to controls (5.1

ROI-based group comparisons and correlations with cognitive scores
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 1, 2022. ; https://doi.org/10. 1101/2022 Group comparison results by two-sample t-tests in each region of interest are shown in Figure 3 and in more detail in Supplementary Table 1. bvFTD caused severe synaptic loss in frontal and temporal lobes bilaterally, with the right cingulate and insula cortex showing the most severe loss (-6.9 ≤ t ≤ -5.6; -2.7 ≤ Cohen's d ≤ -2.2). Results from explorative two-sample t-tests on sub-regions are reported in Supplemental Material, including partial-volume corrected (Supplementary Table 2) and uncorrected (Supplementary Table 3) regional BP ND .
Bayesian correlation analyses indicated strong evidence for the associations between

Discussion
This study confirms the hypothesis that people with a clinical diagnosis of bvFTD have severe and widespread synaptic loss over frontotemporal cortex, including cingulum and insula. The synaptic . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 1, 2022. ; https://doi.org/10.1101/2022.01.30.22270123 doi: medRxiv preprint density in frontal and cingulate regions as quantified with [ 11 C]UCB-J BP ND correlates with patients' cognitive performance. [ 11 C]UCB-J BP ND was not related to the estimated symptom duration or age, in line with previous evidence (Michiels et al., 2021). These principal results were observed with and without partial volume correction, and using both voxel-wise and regional analysis. The loss of synapses detected by [ 11 C]UCB-J PET raises three points of particular importance.
First, the decline of synaptic health -including synaptic density and synaptic plasticity -will directly affect brain connectivity and learning. Synaptic mediation of neurophysiological connectivity underpins cognitive function, while synaptic plasticity is one of the major determinants of learning and memory in multiple cognitive systems. In Alzheimer's disease, synaptic loss is more closely related to cognitive impairment than tau burden, beta-amyloid burden or neuronal loss (Spires-Jones and Hyman, 2014). Such a preeminent relationship may also hold in frontotemporal dementia. The distinctive distribution of synaptic loss in bvFTD across frontotemporal, insula and cingulate cortex is consistent with the typical distribution of its molecular pathologies, and its neurocognitive and behavioural profile. In this study, all of our cases were symptomatic (CDR ≥ 1), although we note that behavioural and cognitive changes can emerge in the presymptomatic and prodromal stages of bvFTD, many years before dementia and diagnosis (Rohrer et al., 2015;Malpetti et al., 2020;Staffaroni et al., 2020); and synaptic loss has been identified in the presymptomatic stage of those with highly penetrant mutations such as C9orf72 expansions (Malpetti et al., 2021). Early synaptic dysfunction in these regions may explain the subtle presymptomatic behavioural change and executive dysfunction. In addition, synaptic loss may determine the neurophysiological signatures of bvFTD as assayed by magnetoencephalography (Hughes et al., 2018;Sami et al., 2018;Adams et al., 2021;Shaw et al., 2021;Copet et al., 2022) as in Alzheimer's disease (Coomans et al., 2021).
Second, quantifying the degree and distribution of synaptic loss can enrich models of frontotemporal dementia pathogenesis, in preclinical and clinical settings. For example, in . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 1, 2022. ; https://doi.org/10.1101/2022.01.30.22270123 doi: medRxiv preprint preclinical tauopathy models, connectivity more than proximity has been shown to influence the spread of diverse toxic oligomeric tau species (Clavaguera et al., 2009(Clavaguera et al., , 2013de Calignon et al., 2012;Iba et al., 2013;Ahmed et al., 2014;Mudher et al., 2017). Several mechanisms have been Third, with a critical role for synaptic health in mediating between the molecular pathology and cognitive-physiological impairment of frontotemporal dementia, the ability to quantify the degree . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 1, 2022. ; https://doi.org/10. 1101/2022 and distribution of synaptic loss can enhance novel experimental medicine studies (Cope et al., 2021). The degree and distribution of loss may be used either for stratification in inclusion or analytical stages of an early-phase clinical trial. It may also be considered as an intermediate marker of efficacy, particularly where the mechanisms of action of a drug is upstream of synaptic loss or is directly related to synaptic resilience and preservation.
[ 11 C]UCB-J is not the only potential marker of synaptic health in frontotemporal dementia, and related disorders. A previous study using [ 18 F]UCB-H PET to assess synaptic loss did not identify a deficit in frontotemporal dementia vs controls, nor was there a difference between frontotemporal dementia and Alzheimer's disease (Salmon et al., 2021). Our study has several limitations. We acknowledge the relatively small sample size. However, the expected effect size in frontotemporal dementia was large (Cohen's d>1), and power was estimated . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 1, 2022. ; https://doi.org/10. 1101/2022 to be sufficient (β>0.8 for α <0.05). Moreover, we found consensus across different analytic methods: voxel-wise and ROI-based analyses, BP ND values determined from data with and without partial-volume correction. The Bayesian tests confirmed that we had sufficient precision (analogous to power in frequentist tests) to support the alternate hypotheses (BFs > 3) with strong evidence from the eleven patients. The convergence over these statistical approaches mitigates against inadequate power and sample-dependant biases on the estimation of group differences and imagingcognition associations. The replication of these findings with larger and multicentre clinical cohorts will nonetheless represent an important step to establish the generalizability of our results, and utility for clinical trials. Recruitment was based on clinical diagnosis, rather than neuropathology or genetics, but the clinical diagnosis was re-confirmed at serial clinical visits and has high clinicopathological correlation with either FTLD-Tau or FTLD-TDP43. Given the novelty of the radiotracer, the cohort has been scanned recently (within 24 months of submission) meaning survival analyses and neuropathological confirmation are not yet possible. Future PET-to-autopsy studies will be needed to investigate the association between in vivo measures of synaptic density and neuropathology. Nonetheless, the concordance of partial-volume-corrected and non-corrected analyses already indicate that the synaptic loss we observe is not simply attributable to atrophy.
To conclude, our study confirms that bvFTD is associated with significant and widespread frontotemporal loss of synapses, in proportion to disease severity. We suggest that [ 11 C]UCB-J PET can facilitate the validation of preclinical models, inform models of human pathogenesis, and inform the design of new disease-modifying treatment strategies.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Sydow A, Van Der Jeugd A, Zheng F, Ahmed T, Balschun D, Petrova O, et al. Tau-induced defects . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 1, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 1, 2022. ;https://doi.org/10.1101https://doi.org/10. /2022  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted February 1, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Figure 2. Voxel-wise synaptic loss and association with cognitive impairments in bvFTD. Panel
A: t maps from voxel-wise analysis showing higher [ 11 C]UCB-J binding potential in controls compared to bvFTD (p < 0.05 FWE-corrected at voxel level). Panels B and C: Coefficient of correlation maps for the bvFTD group between voxel-wise [ 11 C]UCB-J binding potential and cognitive performance at ACE-R and IFS (p < 0.001 uncorrected at voxel level, p < 0.05 FWEcorrected at cluster level).
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 1, 2022. ; https://doi.org/10.1101/2022.01.30.22270123 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 1, 2022. ; https://doi.org/10.1101/2022.01.30.22270123 doi: medRxiv preprint Figure 4. Correlations between regional synaptic density and cognitive performance.
[ 11 C]UCB-J binding potential in a cortical region is reported on the x axis, while the y axis represents a cognitive test score. Abbreviations: ACER = Addenbrooke's cognitive examination revised; BF = Bayes factor; IFS = INECO frontal screening; r = Spearman rho.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 1, 2022. ; https://doi.org/10. 1101/2022